3M (MMM) vs Solventum (SOLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
3M (MMM) has outperformed Solventum (SOLV) over the past year, gaining 5.9% versus a gain of 1.9%. 3M is the larger company by market cap ($91.97 billion vs $14.36 billion), about 6.4 times the size. On valuation, Solventum trades at a lower forward P/E (11.2x vs 17.9x for 3M).
3M pays a dividend yielding 1.72%, while Solventum does not currently pay one. Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 13.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MMM | SOLV |
|---|---|---|
| Share price | $177.99 | $84.50 |
| Market cap | $91.97B | $14.36B |
| 1-day change | -0.27% | -1.52% |
| YTD return | +11.17% | +6.64% |
| 1-year return | +5.89% | +1.93% |
| 5-year return | +21.28% | — |
| P/E ratio (TTM) | 26.57 | 94.94 |
| Forward P/E | 17.94 | 11.20 |
| EPS (TTM) | $6.70 | $0.89 |
| Dividend yield | 1.72% | 0.00% |
| Annual dividend | $3.07 | $0.00 |
| Revenue (latest FY) | $24.95B | $8.32B |
| Revenue growth (YoY) | +1.52% | +0.86% |
| Net income (latest FY) | $3.25B | $1.56B |
| Gross margin | 39.91% | 53.47% |
| Operating margin | 18.55% | 26.20% |
| Net margin | 13.03% | 18.69% |
| 52-week high | $196.90 | $94.16 |
| 52-week low | $139.34 | $62.38 |
| Distance from 52-week high | -9.60% | -10.26% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +9.00% | +16.43% |
| Average volume | 3.28M | 1.03M |
| Shares outstanding | 516.73M | 169.96M |
| Employees | 60,500 | 20,584 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- 3M is about 6.4 times larger than Solventum by market value ($91.97B vs $14.36B).
- Solventum trades at a higher earnings multiple (94.9x vs 26.6x trailing P/E).
- 3M offers a meaningfully higher dividend yield (1.72% vs 0.00%).
- Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus 13.0 cents for 3M.
About 3M
MMM stock →3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer.
Health Care · Medical/Dental Instruments · 60,500 employees
About Solventum
SOLV stock →Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Health Care · Medical/Dental Instruments · 20,584 employees
MMM vs SOLV FAQ
Which is bigger, 3M or Solventum?
3M (MMM) is larger, with a market capitalization of $91.97B compared with $14.36B for Solventum (SOLV).
Which stock has performed better over the past year, MMM or SOLV?
MMM returned +5.89% over the past 12 months, compared with +1.93% for SOLV (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, MMM or SOLV?
MMM has the lower trailing P/E at 26.6, versus 94.9 for SOLV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, 3M or Solventum?
3M pays a dividend yielding 1.72%, while Solventum does not currently pay a regular dividend.
Are 3M and Solventum in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.